Practical leak detection and leak rate measurement applied to a hot cell for radiopharmaceuticals preparations in a GMP compliant Laboratory
DOI:
https://doi.org/10.15392/2319-0612.2026.3004Palabras clave:
hot cell, leak tightness, pressure change method, radiopharmaceuticalResumen
Hot cells are containment systems used in radiopharmaceutical production, designed to ensure radiation protection and product quality. Leak tightness testing is a mandatory requirement under CNEN NN 6.13 standard, as it directly impacts worker safety, environmental protection, and product integrity. This study aimed to perform a practical pressure change leak test in a hot cell used for radiopharmaceutical preparations, in accordance with applicable technical standards. The pressure change method was applied using pressures between 1.6 and 2.5 higher the working pressure for a testing time of 15 minutes. The method proved practical, requiring no highly specialized equipment, although its sensitivity to temperature highlights the importance of high-precision thermometer. Results showed that while the method is suitable for ISO 10648-2:1994 Class 2 compliance, it may not be adequate for Class 1 due to the risk of mathematically inaccurate results under temperature variations. Multiple rounds of leak detection and repair were required to achieve the required containment level. Overall, the DC, RIC, CIC, and Solid Waste chambers met Class 2 leak tightness requirements, being suitable for use in radiopharmacy facilities.
Descargas
Referencias
[1] ELLIOTT, A. T.; HILDITCH, T. E., MURRAY, T.; MCNULTY, H. The design and construction of a central radiopharmacy. Nuclear medicine communications, v. 14, n. 4, p. 328-334, 1993. DOI: https://doi.org/10.1097/00006231-199304000-00174
[2] SAHA, G. B. Radiopharmaceuticals and Methods of Radiolabeling. In: Fundamentals of nuclear pharmacy. Cleveland: The Cleveland Clinic Foundation, 1998. P. 79-110. ISBN 0-387-40360-4.
[3] VIDAL, A. et al. ARRONAX Cyclotron: Setting up of In‐House Hospital Radiopharmacy. BioMed Research International, v. 2020, n. 1, p. 1572841, 2020. DOI: https://doi.org/10.1155/2020/1572841
[4] OLIVEIRA, S. R.; LEÃO, C. A. História da radiofarmácia e as implicações da Emenda Constitucional n. 49. Revista Brasileira de Ciências Farmacêuticas, v. 44, p. 377-382, 2008. DOI: https://doi.org/10.1590/S1516-93322008000300006
[5] Araújo E. B. et al. Garantia da qualidade aplicada à produção de radiofármacos. Revista Brasileira de Ciências Farmacêuticas, v. 44, p. 1-12, 2008. Available at: https://doi.org/10.1590/S1516-93322008000100002 DOI: https://doi.org/10.1590/S1516-93322008000100002
[6] BRASIL - National Health Surveillance Agency of the Ministry of Health, 2022. Resolution of the collegiate board (RDC) No. 658. Available at: https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-658-de-30-de-marco-de-2022-389846242 .
[7] CALIXTO, J. B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Brazilian Journal of medical and Biological research, v. 33, p. 179-189, 2000. DOI: https://doi.org/10.1590/S0100-879X2000000200004
[8] PATEL, K. T.; CHOTAI, N. P. Pharmaceutical GMP: past, present, and future–a review. Die Pharmazie-An International Journal of Pharmaceutical Sciences, v. 63, n. 4, p. 251-255, 2008.
[9] BRASIL - National Health Surveillance Agency of the Ministry of Health, 2022. Normative Instruction (IN) No. 128. Available at: https://www.in.gov.br/en/web/dou/-/instrucao-normativa-pres/inss-n-128-de-28-de-marco-de-2022-389275446
[10] SANTOS, O. R. et al. Radiopharmaceuticals Industry Based On the Brazilian Regulations. FABAD Journal of Pharmaceutical Sciences, v. 33, n. 4, p. 205, 2008.
[11] CAMPOS, F. E.; ARAÚJO, E. B. Air system in the hot cell for injectable radiopharmaceutical production: requirements for personnel and environment safety and protection of the product. INAC: International Nuclear Atlantic Conference Innovations in nuclear technology for a sustainable future. Brazil, 2009.
[12] BORRELLI, R. A. Functional components for a design strategy: hot cell shielding in the high reliability safeguards methodology. Nuclear Engineering and Design, v. 305, p. 18-27, 2016. DOI: https://doi.org/10.1016/j.nucengdes.2016.05.010
[13] TODDLE, S. et al. Guidance on validation and qualification of processes and operations involving radiopharmaceuticals. EJNMMI radiopharmacy and chemistry, v. 2, p. 1-29, 2017. DOI: https://doi.org/10.1186/s41181-017-0025-9
[14] INTERNATIONAL ATOMIC ENERGY AGENCY. Radioisotope Handling Facilities and Automation of Radioisotope Production (IAEA-TECDOC-1430). Vienna: 2004.
[15] INTERNATIONAL ORGANIZATION FOR STANDARDIZATION. ISO 10648-2: 1994, Containment Enclosures-Part 2: Classification According to Leak Tightness and Associated Checking Methods. Switzerland, 1994.
[16] HU, Shih-Cheng et al. Validation of leak test models for pharmaceutical isolators. International Journal of Engineering & Technology, v. 4, n. 2, p. 311-319, 2015. DOI: https://doi.org/10.14419/ijet.v4i2.4432
[17] LEPETIT, L.; CORTES, P.; THOMAS, L. Progress of ISO standards on the confinement systems in fusion facilities using tritium. Fusion Science and Technology, v. 71, n. 4, p. 639-643, 2017. DOI: https://doi.org/10.1080/15361055.2017.1290951
[18] COLES, T. Leak Rate Measurement for Pharmaceutical Isolators: Practical Guidance for Operators and Test Engineers. Clean Air and Containment Review, 2012, 11: 8-12.
[19] COMISSÃO NACIONAL DE ENERGIA NUCLEAR. Norma NN 6.13 Requisitos de Segurança e Proteção Radiológica em Instalações de Radiofarmácias Centralizadas e Industriais. Diário Oficial da União, Rio de Janeiro, dezembro de 2022. Avaliable at: https://www.gov.br/cnen/pt-br/acesso-rapido/normas/grupo-6/grupo6-nrm613.pdf
[20] INTERNATIONAL ORGANIZATION FOR STANDARDIZATION. ISO 14644-7: 2004, Cleanrooms and Associated Controlled Environments-Part 7: Separative Devices(Clean Air Hoods, Gloveboxes, Isolators and Mini-environments). Switzerland, 2004.
[21] COLES, T.; NEIGER, J. Expression of Isolator Leak RatePercentage Volume Change per Hour A Guide for Normal People. The Scottish Society for Contamination Control, 2004, 49: 2-6.
[22] WEIJING, P. et al. Study on the pressure change method for testing the integrity of the isolation system for sterility testing. Chinese Journal of Pharmaceutical Affairs, v. 33, n. 7, pp. 803-808, 2019.
[23] MIDCALF, B. Pharmaceutical isolators: a guide to their application, design and control. London, UK: Pharmaceutical Press, 2004. p 101-122. ISBN 0-85369-573 3.2004.
[24] International Organization for Standardization. ISO 14644-1: 2015, Cleanrooms and Associated Controlled Environments- Part 1: Classification of air cleanliness by particle concentration. Switzerland, 2015.
Descargas
Publicado
Número
Sección
Categorías
Licencia
Derechos de autor 2026 Rodrigo da Silveira Santos, Carlos Leonel Zapparoli, Joel Mendes dos Santos, Gabriela Franco da Rosa Caetano, Marcelo de Gusmão Paraíso Cavalcanti, Delvonei Alves de Andrade

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Licencia: los artículos de BJRS tienen una licencia internacional Creative Commons Attribution 4.0, que permite el uso, el intercambio, la adaptación, la distribución y la reproducción en cualquier medio o formato, siempre que se otorgue el crédito correspondiente al autor o autores originales y a la fuente, proporcione un enlace a la licencia Creative Commons e indique si se realizaron cambios. Las imágenes u otros materiales de terceros en el artículo están incluidos en la licencia Creative Commons del artículo, a menos que se indique lo contrario en una línea de crédito al material. Si el material no está incluido en la licencia Creative Commons del artículo y su uso previsto no está permitido por la regulación legal o excede el uso permitido, el autor deberá obtener el permiso directamente del titular de los derechos de autor. Para ver una copia de esta licencia, visite http://creativecommons.org/licenses/by/4.0/






















